The US FDA has issued draft guidance supporting the use of Bayesian statistical models in drug and biologic trials, enabling sponsors to integrate prior and real-world data into study designs. This ...
The ability to make adaptive decisions in uncertain environments is a fundamental characteristic of biological intelligence. Historically, computational ...
Clinical trials are evolving fast, with AI, real-world data, and advanced analytics reshaping how studies are designed, run, and analyzed. From integrating electronic health records to adopting ...